comprehensive -WSS

comprehensive

author：explore 2025-09-30 22:10:49 - browse：671

Brain cancer — Michelle Monje/Stanford University/NIH

Tocagen (TOCA) said Tuesday that a Phase 3 clinical trial involving a novel gene therapy for aggressive brain tumors will continue to a final analysis later this year, following an interim look at patient survival data conducted by independent monitors. Tocagen’s stock price dropped sharply.

The San Diego-based biotech pitched the study’s continuation as an encouraging sign for its gene therapy called Toca 511/Toca FC, which is designed to deliver a localized chemotherapy directly to the site of brain tumors.

“We believe the longer-term follow-up of patients in the final analysis, particularly for those randomized in the second enrollment period, will be important in assessing both primary and secondary endpoints,” said Tocagen CEO Marty Duvall, in a statement.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The high cost of giving birth even with insurance
Next article： White House Covid adviser calls on docs to combat misinformation

WSS

Sana to lay off nearly a third of staff, de

FDA panel to weigh safety of artificial wombs for preterm births

AI can decode, harness the power of the humane immune system

'A game

PBMs drew scrutiny in House hearing — and so did pharma

Transgender sports debate: Physicians say bans are health issue

explore

comprehensive

Wikipedia

Affirmative action in medical school literally saved lives

Information blocking fines are now fair game in health care

At least 13 dead in Texas as scorching temps continue

People with substance use disorder deserve online privacy

Hollywood unions extend contract negotiations for actors

Patients, doctors press FTC to beef up hospital merger scrutiny

Sports medicine is finally prioritizing gender equality

How the messy conversation about Dolly changed bioethics

Trump demands the U.S. pay no more for drugs than other countries … again

Physician executives need more than on

Wikipedia

The struggle to figure out which patients 'deserve' Wegovy

Liquid biopsy for lung cancer is launched by Delfi

AI can decode, harness the power of the humane immune system

What to expect at HLTH 2023, the health care industry conference

Akili changes sales model for its ADHD video game treatment

What to expect at HLTH 2023, the health care industry conference

Wikipedia

knowledge

entertainment

focus